Delivery Order SPE2DB22D2007-SPE2DB25FJ2QV
- Not listed
- The Defense Logistics Agency awarded a $5,168.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed price contract, with an ultimate completion date of August 13, 2025. This is a non-set-aside, competitively awarded delivery order issued on July 23, 2025, with performance to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $10,257.48, with an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $4,818.00 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX with a ceiling value of $230,793.30. This firm fixed-price, competitively awarded contract was executed on July 25, 2025, with an ultimate completion date of August 15, 2025. The award carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $20,514.96 to supply 200-unit vials of BOTOX on a firm fixed price basis. The contract, which became effective on June 2, 2025, with completion targeted for June 24, 2025, represents a non-competitive delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $3,419.20 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the prime contractor. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $36,135 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with an ultimate completion date of August 28, 2025. This non-set-aside contract was competitively awarded on August 7, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2QVDelivery Order
The Defense Logistics Agency awarded a $20,514.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with a completion date of July 22, 2025. This competitive award, with no set-aside designation, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with performance for this order also based in Conshohocken. The delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply medications, medical devices, and related commodities to military healthcare systems and other federal agencies. The IDC supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities with specialized medications and medical supplies across multiple therapeutic domains. DLA Troop Support Medical maintains flexibility in its pharmaceutical procurement strategy and has indicated plans to establish the Pharmaceutical Prime Vendor Global Program Generation V with multiple regional awards, positioning AmerisourceBergen as one of several potential contractors supporting federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 6/30/25 |